TargetGeneReg
TargetGeneReg maps gene regulatory interactions mediated by p53, ΔNp63, RFX7, and cell cycle signaling by integrating gene expression and transcription factor DNA-binding data to characterize responses of coding and non-coding genes.
Key Features:
- Expanded Database: Includes coding and non-coding genes and annotations for transcription factors p53, ΔNp63, and RFX7.
- Integration of Multi-Omics Data: Combines gene expression profiling with transcription factor DNA-binding data for joint analysis.
- Dissection of Regulatory Effects: Identifies common and context-specific regulatory responses across cell types and treatment conditions.
- Candidate Identification and Validation: Facilitates selection of genes responsive to p53, ΔNp63, or cell cycle signals for downstream validation.
Scientific Applications:
- Cancer Research: Analyzes dysregulation of p53 and cell cycle pathways to support studies of tumor biology.
- Therapeutic Target and Biomarker Discovery: Supports identification of candidate therapeutic targets and biomarkers based on regulatory responses.
- Non-coding and Epigenetic Regulation Studies: Enables analysis of non-coding genes to investigate epigenetic and post-transcriptional regulatory mechanisms.
Methodology:
Integration of gene expression profiling with transcription factor DNA-binding data to determine gene-specific responses to p53, ΔNp63, and cell cycle signaling.
Topics
Details
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 5/16/2022
- Last Updated:
- 5/16/2022
Operations
Publications
Fischer M, Schwarz R, Riege K, DeCaprio JA, Hoffmann S. TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation. NAR Cancer. 2022;4(1). doi:10.1093/narcan/zcac009. PMID:35350773. PMCID:PMC8946727.
PMID: 35350773
PMCID: PMC8946727
Funding: - German Federal Ministry for Education and Research: 031L016D
- National Institutes of Health: P01CA203655, R35CA232128